An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy

The myostatin/activin type II receptor (ActRII) pathway has been identified to be critical in regulating skeletal muscle size. Several other ligands, including GDF11 and the activins, signal through this pathway, suggesting that the ActRII receptors are major regulatory nodes in the regulation of mu...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Lach-Trifilieff, Estelle, Minetti, Giulia C., Sheppard, KellyAnn, Ibebunjo, Chikwendu, Feige, Jerome N., Hartmann, Steffen, Brachat, Sophie, Rivet, Helene, Koelbing, Claudia, Morvan, Frederic, Hatakeyama, Shinji, Glass, David J.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology 2014
Θέματα:
Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3911487/
https://ncbi.nlm.nih.gov/pubmed/24298022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/MCB.01307-13
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια